May 23, 2025

New Inhaled Treprostinil Option Approved

Yutrepia represents an additional therapeutic option within the prostacyclin class for the management of PAH and PH-ILD.

Conexiant

May 23, 2025

BP Pills: Does Timing Matter? 

A large Canadian study of 3,357 patients found that taking blood pressure medication at bedtime did not reduce deaths or heart events compared to morning dosing.

Conexiant

May 23, 2025

BP Pills: Does Timing Matter? 

A large Canadian study of 3,357 patients found that taking blood pressure medication at bedtime did not reduce deaths or heart events compared to morning dosing.

Conexiant

May 23, 2025

JAK Inhibitors Prove Best for COVID

A global analysis finds JAK inhibitors significantly reduce COVID-19 deaths and ventilation needs in hospitalized patients, outperforming other therapies.

Reuters

May 23, 2025

Early-Stage Nonrectal Mismatch Repair–Deficient Tumors Respond to Neoadjuvant PD-1 Blockade, Facilitating Nonoperative Management

Mismatch repair–deficient (dMMR) tumors beyond those in the rectum may respond to PD-1 blockade in the neoadjuvant setting, offering the option of organ preservation in early-stage cancer regardless o...

The ASCO Post

May 23, 2025

BMI, Glucose, Blood Pressure Linked to Multimorbidity

A 30-year cohort study found that life-course factors—including BMI, blood pressure, and glucose—significantly influence chronic disease accumulation, but much of the risk remains unexplained.

Conexiant

May 22, 2025

At-Home HPV Test Matches Clinic Accuracy

Researchers found that an at-home self-collection device for HPV testing demonstrated high accuracy and safety, matching clinician-collected results for cervical cancer screening.

Conexiant

May 22, 2025

GLP-1 RAs May Lower Risk of Obesity-Related Cancers

A large observational study aimed to evaluate whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) or dipeptidyl peptidase–4 inhibitors may reduce the risk of obesity-related cancers more eff...

The ASCO Post

May 22, 2025

Cardiogenic Shock in Women: Treatment Disparities Persist

New expert consensus statement reveals that women with cardiogenic shock face significant treatment disparities and outlines evidence-based recommendations for improving outcomes.

Conexiant